Besivance is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Besifloxacin.
| Product ID | 50090-1241_354afd39-0900-4c16-be1a-e47978ab280c |
| NDC | 50090-1241 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Besivance |
| Generic Name | Besifloxacin |
| Dosage Form | Suspension |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2009-05-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022308 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | BESIFLOXACIN |
| Active Ingredient Strength | 6 mg/mL |
| Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2014-11-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022308 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2014-11-28 |
| Marketing End Date | 2019-12-31 |
| Ingredient | Strength |
|---|---|
| BESIFLOXACIN | 6 mg/mL |
| SPL SET ID: | b111b1ab-10b0-4378-8aef-e51d5274306c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24208-446 | Besivance | Besifloxacin |
| 50090-1241 | Besivance | Besifloxacin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BESIVANCE 77632895 3796795 Live/Registered |
BAUSCH & LOMB INCORPORATED 2008-12-15 |